https://orcid.org/0000-0001-8363-1999
-
Views
-
Cite
Cite
Henrik N Kløverpris, Reuben McGregor, James E McLaren, Kristin Ladell, Mikkel Harndahl, Anette Stryhn, Jonathan M Carlson, Catherine Koofhethile, Bram Gerritsen, Can Keşmir, Fabian Chen, Lynn Riddell, Graz Luzzi, Alasdair Leslie, Bruce D Walker, Thumbi Ndung’u, Søren Buus, David A Price, Philip J Goulder, CD8+ TCR Bias and Immunodominance in HIV-1 Infection, The Journal of Immunology, Volume 194, Issue 11, June 2015, Pages 5329–5345, https://doi.org/10.4049/jimmunol.1400854
Close - Share Icon Share
Abstract
Immunodominance describes a phenomenon whereby the immune system consistently targets only a fraction of the available Ag pool derived from a given pathogen. In the case of CD8+ T cells, these constrained epitope-targeting patterns are linked to HLA class I expression and determine disease progression. Despite the biological importance of these predetermined response hierarchies, little is known about the factors that control immunodominance in vivo. In this study, we conducted an extensive analysis of CD8+ T cell responses restricted by a single HLA class I molecule to evaluate the mechanisms that contribute to epitope-targeting frequency and antiviral efficacy in HIV-1 infection. A clear immunodominance hierarchy was observed across 20 epitopes restricted by HLA-B*42:01, which is highly prevalent in populations of African origin. Moreover, in line with previous studies, Gag-specific responses and targeting breadth were associated with lower viral load set-points. However, peptide–HLA-B*42:01 binding affinity and stability were not significantly linked with targeting frequencies. Instead, immunodominance correlated with epitope-specific usage of public TCRs, defined as amino acid residue–identical TRB sequences that occur in multiple individuals. Collectively, these results provide important insights into a potential link between shared TCR recruitment, immunodominance, and antiviral efficacy in a major human infection.
